Sinovac to Supply Flu Drugs to Hong Kong and Beijing

24 October 2010 (Last Updated October 24th, 2010 18:30)

Sinovac Biotech has been selected to supply seasonal influenza vaccine Anflu to health authorities in Hong Kong and Beijing. The company received a certificate of drug/product registration from the Hong Kong Department of Health for the vaccine after an application was made in November

Sinovac Biotech has been selected to supply seasonal influenza vaccine Anflu to health authorities in Hong Kong and Beijing.

The company received a certificate of drug/product registration from the Hong Kong Department of Health for the vaccine after an application was made in November 2009.

Anflu was also selected by the Beijing Centers for Disease Control and Prevention to supply 375,000 doses valued at $1.3m.

Anflu is one of five vaccines selected for use in Beijing.